Cerenion share issue of up to 2 million euros now open

Cerenion Oy, the next-generation brain monitoring company, opened a capital raise round of 1-2 million euros on Thursday last week. The round offers interested parties the opportunity to take part in Cerenion’s path to improving intensive care.
"Our technology is unique and the first of its kind on the market", reports Timo Koskela, CEO of Cerenion. "Our upcoming product has several applications and significant market potential in, for example, modern intensive care units, which we estimate to be a market worth 650 million euros annually", he continues. The first C-Trend™-enabled EEG product is currently expected to be released by Bittium Corporation in 2019.
The round is run by the investment house Springvest, who has a strong track record in organizing multi-million euro capital raise rounds in Finland. Springvest, founded in 2012, has so far organized 49 rounds raising 88 million euros of investment for promising unlisted growth companies.
Cerenion’s current funders, the Finnish venture capital firms Butterfly Ventures and Icebreaker.vc, will participate in the round. "Cerenion has attracted significant investors and Butterfly Ventures and Icebreaker.vc will invest more during this share issue. Those now investing through Springvest have the opportunity to participate in the round with the same terms as Butterfly Ventures and Icebreaker.vc", says Päivi Malinen, CEO of Springvest.
The investment round will end on the 13th of September. More information on the round is available at Springvest’s site, see link below.
To date Cerenion has raised over a million euros for the development of its technology and business. The prospects for Cerenion are very promising as its technology provides potentially invaluable information for the intensive care market which is estimated at 200 billion euros worldwide.
Springvest Oy is a modern investment house, regulated by the Finnish Financial Supervisory Authority. We serve the most promising growth companies looking for an effective, trustworthy, and easy way to raise capital. Primarily, we focus on A rounds. We provide opportunities to invest in promising unlisted growth companies.
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
Cerenion Oy
Firdonkatu 2 T 63
00520 Helsinki
Call us: +358 50 447 4909
E-mail us:
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2021 Cerenion Oy